{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:38:31Z","timestamp":1791923911235,"version":"4.3.4"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/nrneph.2013.110","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T03:14:09Z","timestamp":1371525249000},"page":"459-469","source":"Crossref","is-referenced-by-count":426,"title":["Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis"],"prefix":"10.1038","volume":"9","author":[{"given":"Nancy J.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"BFnrneph2013110_CR1","doi-asserted-by":"crossref","first-page":"16973","DOI":"10.1074\/jbc.274.24.16973","volume":"274","author":"A N\u00e1ray-Fejes-T\u00f3th","year":"1999","unstructured":"N\u00e1ray-Fejes-T\u00f3th, A., Canessa, C., Cleaveland, E. S., Aldrich, G. & Fejes-T\u00f3th, G. sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels. J. Biol. Chem. 274, 16973\u201316978 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2013110_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1074\/jbc.C100623200","volume":"277","author":"PM Snyder","year":"2002","unstructured":"Snyder, P. M., Olson, D. R. & Thomas, B. C. Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel. J. Biol. Chem. 277, 5\u20138 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2013110_CR3","doi-asserted-by":"crossref","first-page":"F714","DOI":"10.1152\/ajprenal.00061.2006","volume":"291","author":"V Bhalla","year":"2006","unstructured":"Bhalla, V., Soundararajan, R., Pao, A. C., Li, H. & Pearce, D. Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. Am. J. Physiol. Renal Physiol. 291, F714\u2013F721 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR4","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI38323","volume":"119","author":"DJ Rozansky","year":"2009","unstructured":"Rozansky, D. J.  et al. Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway. J. Clin. Invest. 119, 2601\u20132612 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013110_CR5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1681\/ASN.2011020132","volume":"22","author":"JP Arroyo","year":"2011","unstructured":"Arroyo, J. P.  et al. Nedd4\u20132 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4\u20132 pathway. J. Am. Soc. Nephrol. 22, 1707\u20131719 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR6","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/endo.137.10.8828470","volume":"137","author":"A Sato","year":"1996","unstructured":"Sato, A. & Funder, J. W. High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology 137, 4145\u20134153 (1996).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","volume":"71","author":"M Lombes","year":"1992","unstructured":"Lombes, M.  et al. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ. Res. 71, 503\u2013510 (1992).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1681\/ASN.2005020129","volume":"16","author":"Y Terada","year":"2005","unstructured":"Terada, Y.  et al. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1\/2, cyclin D1, and cyclin A. J Am. Soc. Nephrol. 16, 2296\u20132305 (2005).","journal-title":"J Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata, S., Nagase, M., Yoshida, S., Kawachi, H. & Fujita, T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49, 355\u2013364 (2007).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR10","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo, C.  et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 117, 2253\u20132261 (2008).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR11","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2003-031545","volume":"89","author":"LA Calo","year":"2004","unstructured":"Calo, L. A.  et al. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J. Clin. Endocrinol. Metab 89, 1973\u20131976 (2004).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"BFnrneph2013110_CR12","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla, C. G. & Weber, K. T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 120, 893\u2013901 (1992).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph2013110_CR13","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","volume":"106","author":"P Lacolley","year":"2002","unstructured":"Lacolley, P.  et al. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats effects of eplerenone. Circulation 106, 2848\u20132853 (2002).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"EL Greene","year":"1996","unstructured":"Greene, E. L., Kren, S. & Hostetter, T. H. Role of aldosterone in the remnant kidney model in the rat. J. Clin. Invest. 98, 1063\u20131068 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013110_CR15","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha, R.  et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 283, H1802\u2013H1810 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrneph2013110_CR16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi, E. R.  et al. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 63, 1791\u20131800 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR17","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00113.2003","volume":"285","author":"IC Gerling","year":"2003","unstructured":"Gerling, I. C.  et al. Aldosteronism: an immunostimulatory state precedes proinflammatory\/fibrogenic cardiac phenotype. Am. J. Physiol. Heart Circ. Physiol. 285, H813\u2013H821 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrneph2013110_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","volume":"25","author":"CG Brilla","year":"1993","unstructured":"Brilla, C. G., Matsubara, L. S. & Weber, K. T. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J. Mol. Cell. Cardiol. 25, 563\u2013575 (1993).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrneph2013110_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt, B.  et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709\u2013717 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013110_CR20","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad, F., Alla, F., Dousset, B., Perez, A. & Pitt, B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102, 2700\u20132706 (2000).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt, B.  et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309\u20131321 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013110_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad, F.  et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364, 11\u201321 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013110_CR23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11906-011-0202-2","volume":"13","author":"MJ Volk","year":"2011","unstructured":"Volk, M. J., Bomback, A. S. & Klemmer, P. J. Mineralocorticoid receptor blockade in chronic kidney disease. Curr. Hypertens. Rep. 13, 282\u2013288 (2011).","journal-title":"Curr. Hypertens. Rep."},{"key":"BFnrneph2013110_CR24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","volume":"37","author":"A Fiebeler","year":"2001","unstructured":"Fiebeler, A.  et al. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension 37, 787\u2013793 (2001).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/nm.2506","volume":"17","author":"BJ He","year":"2011","unstructured":"He, B. J.  et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 17, 1610\u20131618 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph2013110_CR26","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","volume":"109","author":"S Keidar","year":"2004","unstructured":"Keidar, S.  et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 109, 2213\u20132220 (2004).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/en.2007-0864","volume":"149","author":"F Iwashima","year":"2008","unstructured":"Iwashima, F.  et al. Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 149, 1009\u20131014 (2008).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR28","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun, Y.  et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 161, 1773\u20131781 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2013110_CR29","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/en.2006-1157","volume":"148","author":"Y Hirono","year":"2007","unstructured":"Hirono, Y.  et al. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology 148, 1688\u20131696 (2007).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR30","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","volume":"296","author":"S Huang","year":"2009","unstructured":"Huang, S., Zhang, A., Ding, G. & Chen, R. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am. J. Physiol. Renal Physiol. 296, F1323\u2013F1333 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004872-200403000-00016","volume":"22","author":"A Virdis","year":"2004","unstructured":"Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M. & Schiffrin, E. L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22, 535\u2013542 (2004).","journal-title":"J. Hypertens."},{"key":"BFnrneph2013110_CR32","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","volume":"20","author":"S Johar","year":"2006","unstructured":"Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J. & Shah, A. M. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J. 20, 1546\u20131548 (2006).","journal-title":"FASEB J."},{"key":"BFnrneph2013110_CR33","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/en.2006-1691","volume":"148","author":"S Stas","year":"2007","unstructured":"Stas, S.  et al. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of NADPH oxidase and cardiac remodeling. Endocrinology 148, 3773\u20133780 (2007).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","volume":"52","author":"H Matsui","year":"2008","unstructured":"Matsui, H.  et al. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension 52, 287\u2013294 (2008).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1291\/hypres.28.447","volume":"28","author":"K Yoshida","year":"2005","unstructured":"Yoshida, K.  et al. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. Hypertens. Res. 28, 447\u2013455 (2005).","journal-title":"Hypertens. Res."},{"key":"BFnrneph2013110_CR36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.HYP.0000176236.55322.18","volume":"46","author":"MK Rude","year":"2005","unstructured":"Rude, M. K.  et al. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension 46, 555\u2013561 (2005).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR37","first-page":"180","volume":"40","author":"J Yuan","year":"2007","unstructured":"Yuan, J., Jia, R. & Bao, Y. Aldosterone up-regulates production of plasminogen activator inhibitor-1 by renal mesangial cells. J. Biochem. Mol. Biol. 40, 180\u2013188 (2007).","journal-title":"J. Biochem. Mol. Biol."},{"key":"BFnrneph2013110_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","volume":"13","author":"JA Leopold","year":"2007","unstructured":"Leopold, J. A.  et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat. Med. 13, 189\u2013197 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneph2013110_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","volume":"48","author":"D Nagata","year":"2006","unstructured":"Nagata, D.  et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 48, 165\u2013171 (2006).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR40","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0707791104","volume":"104","author":"H Oberleithner","year":"2007","unstructured":"Oberleithner, H.  et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc. Natl Acad. Sci. USA 104, 16281\u201316286 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013110_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00424-011-1038-y","volume":"463","author":"S Korte","year":"2012","unstructured":"Korte, S.  et al. Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch. 463, 269\u2013278 (2012).","journal-title":"Pflugers Arch."},{"key":"BFnrneph2013110_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2012.03.015","volume":"53","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y.  et al. Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic. Biol. Med. 53, 30\u201343 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrneph2013110_CR43","doi-asserted-by":"crossref","first-page":"F723","DOI":"10.1152\/ajprenal.00480.2006","volume":"293","author":"A Zhang","year":"2007","unstructured":"Zhang, A., Jia, Z., Guo, X. & Yang, T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am. J. Physiol. Renal Physiol. 293, F723\u2013F731 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR44","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","volume":"296","author":"S Huang","year":"2009","unstructured":"Huang, S., Zhang, A., Ding, G. & Chen, R. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am. J. Physiol. Renal Physiol. 296, F1323\u2013F1333 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR45","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ajpath.2011.01.029","volume":"178","author":"C Zhu","year":"2011","unstructured":"Zhu, C.  et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARgamma. Am. J. Pathol. 178, 2020\u20132031 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2013110_CR46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ki.2011.29","volume":"80","author":"A Zhang","year":"2011","unstructured":"Zhang, A., Jia, Z., Wang, N., Tidwell, T. J. & Yang, T. Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int. 80, 51\u201360 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","volume":"16","author":"Y Terada","year":"2012","unstructured":"Terada, Y.  et al. Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin. Exp. Nephrol. 16, 81\u201388 (2012).","journal-title":"Clin. Exp. Nephrol."},{"key":"BFnrneph2013110_CR48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2008020232","volume":"20","author":"V Leroy","year":"2009","unstructured":"Leroy, V.  et al. Aldosterone activates NF-kappaB in the collecting duct. J. Am. Soc. Nephrol. 20, 131\u2013144 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR49","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.112.248732","volume":"32","author":"M Yang","year":"2012","unstructured":"Yang, M.  et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 32, 1675\u20131686 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2013110_CR50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00109-006-0082-0","volume":"84","author":"F Artunc","year":"2006","unstructured":"Artunc, F.  et al. Blunted DOCA\/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J. Mol. Med. (Berl) 84, 737\u2013746 (2006).","journal-title":"J. Mol. Med. (Berl)"},{"key":"BFnrneph2013110_CR51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0955-2235(92)90017-C","volume":"4","author":"NA Noble","year":"1992","unstructured":"Noble, N. A., Harper, J. R. & Border, W. A. In vivo interactions of TGF-beta and extracellular matrix. Prog. Growth Factor Res. 4, 369\u2013382 (1992).","journal-title":"Prog. Growth Factor Res."},{"key":"BFnrneph2013110_CR52","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/en.2002-220956","volume":"144","author":"TY Chun","year":"2003","unstructured":"Chun, T. Y., Bloem, L. J. & Pratt, J. H. Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes. Endocrinology 144, 1712\u20131717 (2003).","journal-title":"Endocrinology"},{"issue":"Suppl.","key":"BFnrneph2013110_CR53","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.3346\/jkms.2009.24.S1.S195","volume":"24","author":"JS Han","year":"2009","unstructured":"Han, J. S., Choi, B. S., Yang, C. W. & Kim, Y. S. Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells. J. Korean Med. Sci. 24 (Suppl.), S195\u2013S203 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"BFnrneph2013110_CR54","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","volume":"286","author":"I Juknevicius","year":"2004","unstructured":"Juknevicius, I., Segal, Y., Kren, S., Lee, R. & Hostetter, T. H. Effect of aldosterone on renal transforming growth factor-beta. Am. J. Physiol. Renal Physiol. 286, F1059\u2013F1062 (2004).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR55","first-page":"336","volume":"85","author":"NJ Brown","year":"2000","unstructured":"Brown, N. J.  et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J. Clin. Endocrinol. Metab. 85, 336\u2013344 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2013110_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2005.03.016","volume":"239","author":"TY Chun","year":"2005","unstructured":"Chun, T. Y. & Pratt, J. H. Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes. Mol. Cell Endocrinol. 239, 55\u201361 (2005).","journal-title":"Mol. Cell Endocrinol."},{"key":"BFnrneph2013110_CR57","doi-asserted-by":"crossref","first-page":"F1287","DOI":"10.1152\/ajprenal.00017.2008","volume":"294","author":"W Huang","year":"2008","unstructured":"Huang, W.  et al. Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am. J. Physiol. Renal Physiol. 294, F1287\u2013F1295 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1523-1755.2000.00355.x","volume":"58","author":"JP Rerolle","year":"2000","unstructured":"Rerolle, J. P., Hertig, A., Nguyen, G., Sraer, J. D. & Rondeau, E. P. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int. 58, 1841\u20131850 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR59","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.ki.5000201","volume":"69","author":"J Ma","year":"2006","unstructured":"Ma, J.  et al. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int. 69, 1064\u20131072 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR60","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","volume":"108","author":"EM Oestreicher","year":"2003","unstructured":"Oestreicher, E. M.  et al. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation 108, 2517\u20132523 (2003).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.0000152356.85791.52","volume":"25","author":"AD Weisberg","year":"2005","unstructured":"Weisberg, A. D.  et al. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II\/salt-induced aortic remodeling. Arterioscler. Thromb. Vasc. Biol. 25, 365\u2013371 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2013110_CR62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCULATIONAHA.110.955245","volume":"122","author":"AK Ghosh","year":"2010","unstructured":"Ghosh, A. K.  et al. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. Circulation 122, 1200\u20131209 (2010).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.RES.0000141427.61023.f4","volume":"95","author":"H Moriwaki","year":"2004","unstructured":"Moriwaki, H., Stempien-Otero, A., Kremen, M., Cozen, A. E. & Dichek, D. A. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ. Res. 95, 637\u2013644 (2004).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR64","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/cvr\/27.12.2130","volume":"27","author":"E Guarda","year":"1993","unstructured":"Guarda, E., Katwa, L. C., Myers, P. R., Tyagi, S. C. & Weber, K. T. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27, 2130\u20132134 (1993).","journal-title":"Cardiovasc. Res."},{"key":"BFnrneph2013110_CR65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","volume":"15","author":"JB Park","year":"2002","unstructured":"Park, J. B. & Schiffrin, E. L. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am. J. Hypertens. 15, 164\u2013169 (2002).","journal-title":"Am. J. Hypertens."},{"key":"BFnrneph2013110_CR66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0735-1097(02)02860-7","volume":"41","author":"TM Seccia","year":"2003","unstructured":"Seccia, T. M.  et al. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. J. Am. Coll. Cardiol. 41, 666\u2013673 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2013110_CR67","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00005344-200206000-00015","volume":"39","author":"RC Tostes","year":"2002","unstructured":"Tostes, R. C., Touyz, R. M., He, G., Ammarguellat, F. & Schiffrin, E. L. Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 39, 892\u2013900 (2002).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"BFnrneph2013110_CR68","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.1074\/jbc.M109.030718","volume":"284","author":"LR Stow","year":"2009","unstructured":"Stow, L. R.  et al. Aldosterone modulates steroid receptor binding to the endothelin-1 gene (edn1). J. Biol. Chem. 284, 30087\u201330096 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2013110_CR69","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1172\/JCI40205","volume":"120","author":"IZ Jaffe","year":"2010","unstructured":"Jaffe, I. Z.  et al. Placental growth factor mediates aldosterone-dependent vascular injury in mice. J. Clin. Invest. 120, 3891\u20133900 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2013110_CR70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.RES.0000025268.10302.0C","volume":"91","author":"K Isoda","year":"2002","unstructured":"Isoda, K.  et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ. Res. 91, 77\u201382 (2002).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12020-012-9675-2","volume":"42","author":"GX Fu","year":"2012","unstructured":"Fu, G. X., Xu, C. C., Zhong, Y., Zhu, D. L. & Gao, P. J. Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK. Endocrine 42, 676\u2013683 (2012).","journal-title":"Endocrine"},{"key":"BFnrneph2013110_CR72","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.amjhyper.2003.10.007","volume":"17","author":"F Sam","year":"2004","unstructured":"Sam, F.  et al. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am. J. Hypertens. 17, 188\u2013193 (2004).","journal-title":"Am. J. Hypertens."},{"key":"BFnrneph2013110_CR73","doi-asserted-by":"crossref","first-page":"F833","DOI":"10.1152\/ajprenal.00557.2010","volume":"301","author":"J Irita","year":"2011","unstructured":"Irita, J.  et al. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney. Am. J. Physiol. Renal Physiol. 301, F833\u2013F844 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2012.05.032","volume":"60","author":"DA Morrow","year":"2012","unstructured":"Morrow, D. A. & O'Donoghue, M. L. Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis. J. Am. Coll. Cardiol. 60, 1257\u20131258 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2013110_CR75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier, L.  et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler. Thromb. Vasc. Biol. 33, 67\u201375 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2013110_CR76","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/HYPERTENSIONAHA.111.190512","volume":"59","author":"F Azibani","year":"2012","unstructured":"Azibani, F.  et al. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart. Hypertension 59, 1179\u20131187 (2012).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR77","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.lfs.2012.04.022","volume":"91","author":"K Kimura","year":"2012","unstructured":"Kimura, K., Ohkita, M., Koyama, M. & Matsumura, Y. Reduced NO production rapidly aggravates renal function through the NF-kappaB\/ET-1\/ETA receptor pathway in DOCA-salt-induced hypertensive rats. Life Sci. 91, 644\u2013650 (2012).","journal-title":"Life Sci."},{"key":"BFnrneph2013110_CR78","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2011100985","volume":"23","author":"Y Ogawa","year":"2012","unstructured":"Ogawa, Y.  et al. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J. Am. Soc. Nephrol. 23, 1198\u20131209 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR79","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","volume":"57","author":"C Hellal-Levy","year":"2000","unstructured":"Hellal-Levy, C., Fagart, J., Souque, A. & Rafestin-Oblin, M. E. Mechanistic aspects of mineralocorticoid receptor activation. Kidney Int. 57, 1250\u20131255 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/bbrc.1995.2106","volume":"213","author":"M Christ","year":"1995","unstructured":"Christ, M., Meyer, C., Sippel, K. & Wehling, M. Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochem. Biophys. Res. Commun. 213, 123\u2013129 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2013110_CR81","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","volume":"97","author":"LJ Min","year":"2005","unstructured":"Min, L. J.  et al. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ. Res. 97, 434\u2013442 (2005).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR82","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","volume":"109","author":"I Mazak","year":"2004","unstructured":"Mazak, I.  et al. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109, 2792\u20132800 (2004).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR83","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","volume":"292","author":"C Grossmann","year":"2007","unstructured":"Grossmann, C.  et al. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am. J. Physiol. Endocrinol. Metab. 292, E1790\u2013E1800 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrneph2013110_CR84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.110.153619","volume":"57","author":"V Griol-Charhbili","year":"2011","unstructured":"Griol-Charhbili, V.  et al. Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone\/salt. Hypertension 57, 238\u2013244 (2011).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR85","doi-asserted-by":"crossref","first-page":"e30156","DOI":"10.1371\/journal.pone.0030156","volume":"7","author":"S Messaoudi","year":"2012","unstructured":"Messaoudi, S.  et al. The epidermal growth factor receptor is involved in angiotensin II but not aldosterone\/salt-induced cardiac remodelling. PLoS ONE 7, e30156 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneph2013110_CR86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000322965","volume":"33","author":"K Sinphitukkul","year":"2011","unstructured":"Sinphitukkul, K., Eiam-Ong, S., Manotham, K. & Eiam-Ong, S. Nongenomic effects of aldosterone on renal protein expressions of pEGFR and pERK1\/2 in rat kidney. Am. J. Nephrol. 33, 111\u2013120 (2011).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2013110_CR87","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/HYPERTENSIONAHA.111.176024","volume":"58","author":"VC De Giusti","year":"2011","unstructured":"De Giusti, V. C.  et al. Aldosterone stimulates the cardiac Na(+)\/H(+) exchanger via transactivation of the epidermal growth factor receptor. Hypertension 58, 912\u2013919 (2011).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","volume":"145","author":"AS Mihailidou","year":"2004","unstructured":"Mihailidou, A. S., Mardini, M. & Funder, J. W. Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology 145, 773\u2013780 (2004).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR89","doi-asserted-by":"crossref","first-page":"H1679","DOI":"10.1152\/ajpheart.2000.279.4.H1679","volume":"279","author":"RC Li","year":"2000","unstructured":"Li, R. C.  et al. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 279, H1679\u2013H1689 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrneph2013110_CR90","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCRESAHA.109.196576","volume":"105","author":"CA Lemarie","year":"2009","unstructured":"Lemarie, C. A.  et al. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors. Circ. Res. 105, 852\u2013859 (2009).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR91","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","volume":"18","author":"A McCurley","year":"2012","unstructured":"McCurley, A.  et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 18, 1429\u20131433 (2012).","journal-title":"Nat. Med."},{"key":"BFnrneph2013110_CR92","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/en.2004-1130","volume":"146","author":"L Michea","year":"2005","unstructured":"Michea, L.  et al. Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology 146, 973\u2013980 (2005).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1999.1771","volume":"266","author":"K Haseroth","year":"1999","unstructured":"Haseroth, K.  et al. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem. Biophys. Res. Commun. 266, 257\u2013261 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph2013110_CR94","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/me.2004-0469","volume":"19","author":"C Grossmann","year":"2005","unstructured":"Grossmann, C.  et al. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 19, 1697\u20131710 (2005).","journal-title":"Mol. Endocrinol."},{"key":"BFnrneph2013110_CR95","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","volume":"57","author":"R Gros","year":"2011","unstructured":"Gros, R.  et al. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 57, 442\u2013451 (2011).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cvr\/cvs016","volume":"94","author":"WW Batenburg","year":"2012","unstructured":"Batenburg, W. W., Jansen, P. M., van den Bogaerdt, A. J. & AH, J. D. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc. Res. 94, 136\u2013143 (2012).","journal-title":"Cardiovasc. Res."},{"key":"BFnrneph2013110_CR97","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder, J. W., Pearce, P. T., Smith, R. & Smith, A. I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242, 583\u2013585 (1988).","journal-title":"Science"},{"key":"BFnrneph2013110_CR98","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.steroids.2008.05.009","volume":"73","author":"R Gong","year":"2008","unstructured":"Gong, R., Morris, D. J. & Brem, A. S. Variable expression of 11beta hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells. Steroids 73, 1187\u20131196 (2008).","journal-title":"Steroids"},{"key":"BFnrneph2013110_CR99","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","volume":"120","author":"MG Usher","year":"2010","unstructured":"Usher, M. G.  et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. Clin. Invest 120, 3350\u20133364 (2010).","journal-title":"J. Clin. Invest"},{"key":"BFnrneph2013110_CR100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin, W.  et al. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ. Res. 93, 69\u201376 (2003).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR101","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00101.2009","volume":"297","author":"SH Lee","year":"2009","unstructured":"Lee, S. H.  et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am. J. Physiol. Renal Physiol. 297, F1381\u2013F1390 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR102","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1681\/ASN.2005020129","volume":"16","author":"Y Terada","year":"2005","unstructured":"Terada, Y.  et al. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1\/2, cyclin d1, and cyclin a. J. Am. Soc. Nephrol. 16, 2296\u20132305 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR103","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"AS Mihailidou","year":"2009","unstructured":"Mihailidou, A. S., Loan Le, T. Y., Mardini, M. & Funder, J. W. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54, 1306\u20131312 (2009).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR104","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1210\/en.2007-0209","volume":"148","author":"AJ Rickard","year":"2007","unstructured":"Rickard, A. J., Funder, J. W., Morgan, J., Fuller, P. J. & Young, M. J. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid\/salt administration? Endocrinology 148, 4829\u20134835 (2007).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR105","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1210\/en.2009-1476","volume":"151","author":"MJ Young","year":"2010","unstructured":"Young, M. J., Morgan, J., Brolin, K., Fuller, P. J. & Funder, J. W. Activation of mineralocorticoid receptors by exogenous glucocorticoids and the development of cardiovascular inflammatory responses in adrenalectomized rats. Endocrinology 151, 2622\u20132628 (2010).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR106","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata, S.  et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 1370\u20131376 (2008).","journal-title":"Nat. Med."},{"key":"BFnrneph2013110_CR107","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata, S.  et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J. Clin. Invest 121, 3233\u20133243 (2011).","journal-title":"J. Clin. Invest"},{"key":"BFnrneph2013110_CR108","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1681\/ASN.2011070734","volume":"23","author":"W Kawarazaki","year":"2012","unstructured":"Kawarazaki, W.  et al. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J. Am. Soc. Nephrol. 23, 997\u20131007 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013110_CR109","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.111.185520","volume":"59","author":"M Nagase","year":"2012","unstructured":"Nagase, M.  et al. Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1. Hypertension 59, 500\u2013506 (2012).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1681.2011.05538.x","volume":"39","author":"K Oki","year":"2012","unstructured":"Oki, K., Gomez-Sanchez, E. P. & Gomez-Sanchez, C. E. Role of mineralocorticoid action in the brain in salt-sensitive hypertension. Clin. Exp. Pharmacol. Physiol 39, 90\u201395 (2012).","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"BFnrneph2013110_CR111","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","volume":"123","author":"D Fraccarollo","year":"2011","unstructured":"Fraccarollo, D.  et al. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123, 400\u2013408 (2011).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR112","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.110.163287","volume":"57","author":"A Lother","year":"2011","unstructured":"Lother, A.  et al. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 57, 746\u2013754 (2011).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR113","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","volume":"54","author":"AJ Rickard","year":"2009","unstructured":"Rickard, A. J.  et al. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54, 537\u2013543 (2009).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR114","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/en.2011-2098","volume":"153","author":"LA Bienvenu","year":"2012","unstructured":"Bienvenu, L. A.  et al. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Endocrinology 153, 3416\u20133425 (2012).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR115","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","volume":"102","author":"M Caprio","year":"2008","unstructured":"Caprio, M.  et al. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ. Res. 102, 1359\u20131367 (2008).","journal-title":"Circ. Res."},{"key":"BFnrneph2013110_CR116","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0804037106","volume":"106","author":"Y Jeong","year":"2009","unstructured":"Jeong, Y.  et al. Aldosterone activates endothelial exocytosis. Proc. Natl Acad. Sci. USA 106, 3782\u20133787 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2013110_CR117","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik, T. J.  et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449\u20132460 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2013110_CR118","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.930446","volume":"122","author":"A Vinh","year":"2010","unstructured":"Vinh, A.  et al. Inhibition and genetic ablation of the B7\/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122, 2529\u20132537 (2010).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","volume":"184","author":"AA Herrada","year":"2010","unstructured":"Herrada, A. A.  et al. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J. Immunol. 184, 191\u2013202 (2010).","journal-title":"J. Immunol."},{"key":"BFnrneph2013110_CR120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.181123","volume":"59","author":"DA Kasal","year":"2012","unstructured":"Kasal, D. A.  et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324\u2013330 (2012).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR121","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/HYPERTENSIONAHA.112.198986","volume":"61","author":"S Messaoudi","year":"2013","unstructured":"Messaoudi, S.  et al. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo. Hypertension 61, 361\u2013367 (2013).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR122","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/en.2004-1102","volume":"146","author":"G Lee","year":"2005","unstructured":"Lee, G.  et al. Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. Endocrinology 146, 2650\u20132656 (2005).","journal-title":"Endocrinology"},{"key":"BFnrneph2013110_CR123","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajprenal.00257.2005","volume":"290","author":"N Makhanova","year":"2006","unstructured":"Makhanova, N.  et al. Kidney function in mice lacking aldosterone. Am. J. Physiol. Renal Physiol. 290, F61\u2013F69 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2013110_CR124","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2012.170","volume":"82","author":"JM Luther","year":"2012","unstructured":"Luther, J. M.  et al. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int. 82, 643\u2013651 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph2013110_CR125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJH.0b013e32834103a9","volume":"29","author":"K Rafiq","year":"2011","unstructured":"Rafiq, K.  et al. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J. Hypertens. 29, 290\u2013298 (2011).","journal-title":"J. Hypertens."},{"key":"BFnrneph2013110_CR126","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","volume":"111","author":"A Fiebeler","year":"2005","unstructured":"Fiebeler, A.  et al. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 111, 3087\u20133094 (2005).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR127","first-page":"514","volume":"44","author":"A Fiebeler","year":"2004","unstructured":"Fiebeler, A.  et al. Aldosterone synthase inhibitor FAD286 ameliorates angiotensin II-induced end-organ damage. Hypertension 44, 514\u2013515 (2004).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR128","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/HJH.0b013e32833c2197","volume":"28","author":"A Gamliel-Lazarovich","year":"2010","unstructured":"Gamliel-Lazarovich, A.  et al. FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice. J. Hypertens. 28, 1900\u20131907 (2010).","journal-title":"J. Hypertens."},{"key":"BFnrneph2013110_CR129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","volume":"56","author":"L Amar","year":"2010","unstructured":"Amar, L.  et al. Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism. Hypertension 56, 831\u2013838 (2010).","journal-title":"Hypertension"},{"key":"BFnrneph2013110_CR130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","volume":"31","author":"L Amar","year":"2013","unstructured":"Amar, L., Azizi, M., Menard, J., Peyrard, S. & Plouin, P. F. Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism. J. Hypertens. 31, 624\u2013629 (2013).","journal-title":"J. Hypertens."},{"key":"BFnrneph2013110_CR131","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","volume":"124","author":"DA Calhoun","year":"2011","unstructured":"Calhoun, D. A.  et al. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation 124, 1945\u20131955 (2011).","journal-title":"Circulation"},{"key":"BFnrneph2013110_CR132","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/gfs388","volume":"28","author":"M Azizi","year":"2013","unstructured":"Azizi, M., Amar, L. & Menard, J. Aldosterone synthase inhibition in humans. Nephrol. Dial. Transplant. 28, 36\u201343 (2013).","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:40:31Z","timestamp":1684456831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnrneph2013110"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.110","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}